SynthesisPituitary2025
Pituitary tuberculosis in the pediatric population: a systematic review and case report.
Synthesis in Pituitary, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis review aims to identify and evaluate the management options for pituitary tuberculosis in the pediatric population.
methodsThe study was conducted based on a comprehensive literature review using the PubMed, Cochrane Library, and ScienceDirect electronic databases. The following keywords were used: pituitary gland and tuberculosis or sellar tuberculoma and children or pediatric or adolescent. We limited the results to publications from 2014 to 2025. The study is a systematic review supplemented by a new case presentation.
resultsEight publications containing reports of 8 children with sellar/suprasellar tuberculosis were included to the review. The clinical data, including sex, age at diagnosis, country of origin, symptoms, endocrine disturbances, intracranial location, MRI findings, and treatment, were analyzed. The study was supplemented by a new case presentation in our department. Out of the 9 patients, 6 were female and 3 were male. The mean age was 10.6 years (with the range between 2 and 17 years).
conclusionsDespite undeniable advances in medicine, the development of diagnostic and therapeutic methods, and the use of prophylactic vaccination, BCG (Bacillus Calmette-Guérin) tuberculosis is still a huge healthcare problem. Intrasellar tuberculoma presents a diagnostic challenge for clinicians since it mimics a pituitary adenoma and, therefore, should be included in the differential diagnosis. The lack of clinical and radiological data on tuberculosis, does not rule out the diagnosis of pituitary tuberculosis. The gold standard for the diagnosis of pituitary tumors is a biopsy, performed by a minimally invasive transsphenoidal approach. A delayed diagnosis may lead to permanent endocrine dysfunction. Regular follow-ups are crucial for evaluating the patient's hormone profile and may require lifelong hormone replacement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.